- About this Journal ·
- Abstracting and Indexing ·
- Aims and Scope ·
- Article Processing Charges ·
- Articles in Press ·
- Author Guidelines ·
- Bibliographic Information ·
- Citations to this Journal ·
- Contact Information ·
- Editorial Board ·
- Editorial Workflow ·
- Free eTOC Alerts ·
- Publication Ethics ·
- Reviewers Acknowledgment ·
- Submit a Manuscript ·
- Subscription Information ·
- Table of Contents
Case Reports in Medicine
Volume 2013 (2013), Article ID 903546, 3 pages
Late-Onset Ornithine Carbamoyltransferase Deficiency Accompanying Acute Pancreatitis and Hyperammonemia
1Department of Clinical Emergencies, LIM 51, University of São Paulo School of Medicine, Rua Peixoto Gomide, 515 Conjunto 134, 01409-001 Bela Vista, SP, Brazil
2Department of Gastroenterology, Digestive Surgery Division, University of São Paulo School of Medicine, Avenida Doutor Enéas de Carvalho Aguiar 255, Instituto Central, 9° Andar, Sala 9074, 05403-900 Cerqueira Cesar, SP, Brazil
Received 16 June 2013; Accepted 31 July 2013
Academic Editor: Piotr K. Janicki
Copyright © 2013 Marcel Cerqueira Cesar Machado et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
- B. C. Lanpher, A. Gropman, K. A. Chapman, U. Lichter-Konecki, Urea Cycle Disorders Consortium, and M. L. Summar, “Urea cycle disorders overview,” in GeneReviews [Internet], R. A. Pagon, T. D. Bird, C. R. Dolan, K. Stephens, and M. P. Adam, Eds., University of Washington, Seattle, Seattle, Wash, USA, 1993–2003.
- B. A. McCullough, M. Yudkoff, M. L. Batshaw, J. M. Wilson, S. E. Raper, and M. Tuchman, “Genotype spectrum of ornithine transcarbamylase deficiency: correlation with the clinical and biochemical phenotype,” The American Journal of Medical Genetics, vol. 93, no. 4, pp. 313–319, 2000.
- S. W. Brusilow and N. E. Maestri, “Urea cycle disorders: diagnosis, pathophysiology, and therapy,” Advances in Pediatrics, vol. 43, pp. 127–170, 1996.
- L. Caldovic, H. Morizono, M. G. Panglao, S. F. Cheng, S. Packman, and M. Tuchman, “Null mutations in the N-acetylglutamate synthase gene associated with acute neonatal disease and hyperammonemia,” Human Genetics, vol. 112, no. 4, pp. 364–368, 2003.
- S. Yamaguchi, L. L. Brailey, H. Morizono, A. E. Bale, and M. Tuchman, “Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene,” Human Mutation, vol. 27, no. 7, pp. 626–632, 2006.
- D. E. Choi, K. W. Lee, Y. T. Shin, and K. R. Na, “Hyperammonemia in a patient with late-onset ornithine carbamoyltransferase deficiency,” Journal of Korean Medical Science, vol. 27, no. 5, pp. 556–559, 2012.
- G. A. Diaz, L. S. Krivitzky, M. Mokhtarani et al., “Ammonia control and neurocognitive outcome among urea cycle disorder patients treated with glycerol phenylbutyrate,” Hepatology, vol. 57, no. 6, pp. 2171–2179, 2013.
- F. Maillot and P. Crenn, “Urea cycle disorders in adult patients,” Revue Neurologique, vol. 163, no. 10, pp. 897–903, 2007.
- P. L. Magoulas and A. W. El-Hattab, “Systemic primary carnitine deficiency: an overview of clinical manifestations, diagnosis, and management,” Orphanet Journal of Rare Diseases, vol. 7, article 68, 2012.
- C. M. Mock and K. H. Schwetschenau, “Levocarnitine for valproic-acid-induced hyperammonemic encephalopathy,” The American Journal of Health-System Pharmacy, vol. 69, no. 1, pp. 35–39, 2012.
- C. Wiegand, T. Thompson, G. H. Bock, R. K. Mathis, C. M. Kjellstrand, and S. M. Mauer, “The management of life-threatening hyperammonemia: a comparison of several therapeutic modalities,” Journal of Pediatrics, vol. 96, no. 1, pp. 142–144, 1980.